ReShape Lifesciences™ Receives FDA 510(k) Clearance for the GIBI HD™ Calibration Tubes for use in Gastric and Bariatric Procedures
10 août 2022 12h05 HE
|
ReShape Lifesciences Inc
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at...
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
27 juil. 2022 16h05 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its...
ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds
17 juin 2022 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, announced today that...
ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™
26 mai 2022 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif. and DES MOINES, Iowa, May 26, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company and...
ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update
23 mai 2022 08h00 HE
|
ReShape Lifesciences Inc
March 2022 Revenues Exceeded January’s and February’s, Combined, Indicating DTC Campaign and Other Visibility Activities are Driving Significant Demand for Lap-Band® Procedures Conference Call to be...
ReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards
19 mai 2022 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Vernon...
ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
16 mai 2022 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...
ReShape Lifesciences to Present at the Q2 Investor Summit
26 avr. 2022 08h30 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Bart...
ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
28 mars 2022 16h05 HE
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported...
ReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band®
24 mars 2022 08h30 HE
|
ReShape Lifesciences Inc
New Generation of Patients are Engaged as Evidenced by Surge in Website Traffic and Doctor Referrals Bariatric Surgeons Seeing Increases in Patient Consultations and Procedures Insurance...